Why is Omaxe falling/rising?

As of 22-Sep, Omaxe Ltd's stock price is currently at 85.60, reflecting a decrease of 0.59, or 0.68%. The stock has underperformed its sector today by 0.61%, and it is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past week, Omaxe has seen a decline of 3.41%, and its year-to-date performance shows a significant drop of 22.81%. The company is facing challenges such as a negative book value and a weak long-term fundamental strength, with operating profit declining at an alarming rate of 240.34% over the last five years. Additionally, the stock has generated a return of -26.08% over the past year, while profits have fallen by 63.2%, indicating a troubling financial situation.
In the broader market context, Omaxe's recent performance contrasts sharply with the Sensex, which has gained 0.46% over the past week. The stock's underperformance is further highlighted by a decrease in institutional investor participation, which has fallen by 0.75% in the previous quarter. This decline suggests a lack of confidence from investors who typically have better resources to analyze company fundamentals. Overall, Omaxe's poor financial results, high debt levels, and negative EBITDA contribute to its downward trajectory, making it a risky investment compared to the broader market.